Clinical Trials Browser

Phase 1/2 × Colorectal Neoplasms × apatinib × Clear all

NCT04446091 2020-06-24

A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)

Phase 1/2 Unknown

Gastrointestinal

Colorectal Neoplasms